Customer Spotlight: Queen Mary University Of London's Centre For Predictive In Vitro Models

Queen Mary University London (QMUL) has launched the Centre for Predictive in vitro Models (CPM) to advance the development and use of predictive in vitro models. The Centre includes the Queen Mary+Emulate Organs-on-Chips Centre, which offers access to Emulate's cutting-edge platform technology and organ-chip models. Organs-on-Chips provide superior precision and control compared to traditional testing methods, enabling researchers to test therapeutics and gain a deeper understanding of the human body.
The QM+Emulate Centre is at the forefront of groundbreaking research, such as modeling breast cancer bone metastasis, which allows researchers to study cancer cell behavior in a mechanically active bone tissue environment. This research, funded by prestigious organizations like Cancer Research UK, EPSRC, and the EU, aims to develop innovative treatments for breast and prostate cancer bone metastasis. The success of this research has sparked significant interest in Organ-Chips as predictive model systems in the UK, with more than 20 groups currently building new models.
The Centre provides comprehensive support for researchers, including assistance with experimental design and training on Emulate's organ-chip models. Additionally, the Centre supports grant applications, collaborations, and commercialization efforts. The website offers valuable resources, such as publications, application notes, on-demand webinars, and a blog, covering various applications of this technology.
Discover the future of in vitro modeling at the Queen Mary+Emulate Organs-on-Chips Centre and unlock new possibilities in the field of predictive medicine.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.